 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aravive, Inc. (NASDAQ:ARAV  Get Free Report) saw a large increase in short interest in August. As of August 31st, there was short interest totalling 4,480,000 shares, an increase of 21.4...

Aravive, Inc. (NASDAQ:ARAV) Sees Significant Growth in Short Interest

Aravive, Inc. (NASDAQ:ARAV Get Free Report) has received a consensus rating of Hold from the six analysts that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the ...

Aravive, Inc. (NASDAQ:ARAV) Receives $10.17 Average Target Price from Analysts

Thinking about buying stock in Noco Noco, Inspire Veterinary Partners, Genius Group, Aravive Inc, or Cronos Group? Thinking about buying stock in Noco Noco, Inspire Veterinary Partners, Genius Group, Aravive Inc, or Cronos Group? PR Newswire NEW YORK, Aug. 31, 2023 NEW YORK, Aug. 31, 2023...

Thinking about buying stock in Noco Noco, Inspire Veterinary Partners, Genius Group, Aravive Inc, or Cronos Group?

Aravive, Inc. (NASDAQ:ARAV  Get Free Report) saw some unusual options trading on Monday. Traders purchased 2,997 call options on the company. This is an increase of approximately 322% compared to the average volume of 710 call options. Analysts Set New Price Targets A number of equities ...

Investors Purchase Large Volume of Call Options on Aravive (NASDAQ:ARAV)

Thinking about buying stock in Genius Group, Scilex Holding, Crown Electrokinetics, Aravive, or VERSES AI? Thinking about buying stock in Genius Group, Scilex Holding, Crown Electrokinetics, Aravive, or VERSES AI? PR Newswire NEW YORK, Aug. 28, 2023 NEW YORK, Aug. 28, 2023 /PRNewswire...

Thinking about buying stock in Genius Group, Scilex Holding, Crown Electrokinetics, Aravive, or VERSES AI?

Aravive, Inc. (NASDAQ:ARAV  Free Report)  Research analysts at William Blair boosted their Q3 2023 earnings estimates for shares of Aravive in a note issued to investors on Tuesday, August 22nd. William Blair analyst A. Hsieh now anticipates that the company will post earnings of ($0....

Aravive, Inc. (NASDAQ:ARAV) to Post Q3 2023 Earnings of ($0.16) Per Share, William Blair Forecasts

Aravive (NASDAQ:ARAV Get Free Report) was downgraded by Cantor Fitzgerald from an overweight rating to a neutral rating in a research report issued on Tuesday, Marketbeat reports. Several other brokerages have also recently weighed in on ARAV. William Blair cut Aravive from an outperform rating to a...

Aravive (NASDAQ:ARAV) Cut to Neutral at Cantor Fitzgerald

Monday,Aravive Inc(NASDAQ: ARAV)filedits quarterly 10Q

 Latest Ratings for ARAV
 DateFirmActionFromTo Mar 2021BTIGInitiates Coverage OnBuy Sep 2020William BlairInitiates Coverage OnOutperform Jul 2020HC Wainwright & Co.MaintainsBuy
 View More Analyst Ratings for ARAV

 View the Latest Analyst ...

Analyst Downgrades Aravive: Grapples With Trial Setback, Strategic Alternatives

Cantor cuts Aravive to neutral as biotech struggles to stay in business

Thinking about buying stock in T2 Biosystems, Oppfi, American Lithium, Zynerba Pharmaceuticals, or Aravive? Thinking about buying stock in T2 Biosystems, Oppfi, American Lithium, Zynerba Pharmaceuticals, or Aravive? PR Newswire NEW YORK, Aug. 15, 2023 NEW YORK, Aug. 15, 2023 /PRNewswire...

Thinking about buying stock in T2 Biosystems, Oppfi, American Lithium, Zynerba Pharmaceuticals, or Aravive?

Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company was founded on December 10, 2008 and is headquartered in Houston, TX.

Watchers	3,179
52-Wk Low	$0.1104
52-Wk High	$2.46

Market Cap	$10.2M
Volume (M)	1.24M
52-Wk High	$2.46
52-Wk Low	$0.1104

ARAV Aravive Inc

About

Feed

News

Sentiment

Fundamentals